Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
larger decrease » marked decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
larger decrease » marked decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
-
2601
Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models.
Published 2025Subjects: -
2602
-
2603
The characteristics of patient groups were used to prove the method’s applicability.
Published 2025Subjects: -
2604
-
2605
-
2606
-
2607
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
2608
-
2609
-
2610
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
2611
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
2612
-
2613
-
2614
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: -
2615
-
2616
-
2617
-
2618
-
2619
-
2620